{"DataElement":{"publicId":"12253687","version":"1","preferredName":"New Cancer Diagnosis Type","preferredDefinition":"Response indicating the diagnosis type of new cancer.","longName":"CHSINIDX","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"2013918","version":"1","preferredName":"New Cancer Diagnosis","preferredDefinition":"the diagnosis of a patient's new primary cancer.","longName":"NEW_CA_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206435","version":"1","preferredName":"New Malignant Neoplasm","preferredDefinition":"New; having no previous example or precedent or parallel.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25586:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F516-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177541","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"Diagnosis","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C6-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2056FBC-6436-69BA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"12245583","version":"1","preferredName":"Cancer Diagnosis Type","preferredDefinition":"General term for detecting and classifying cancer in patients._Something distinguishable as an identifiable class based on common qualities.","longName":"12245583v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Solid organ tumors associated with HPV infection","valueDescription":null,"ValueMeaning":{"publicId":"12245584","version":"1","preferredName":"Solid Organ Neoplasm HPV Infection Relationship","longName":"12245584v1.00","preferredDefinition":"An internal organ with firm consistency without a liquid or hollow structural component._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A strain of papillomavirus that can infect the skin and mucous membranes of humans._A state of connectedness between people, objects, or events; to be associated or connected with something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Organ","conceptCode":"C124068","definition":"An internal organ with firm consistency without a liquid or hollow structural component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Human Papillomavirus","conceptCode":"C14226","definition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FCB06D-3FC4-7C71-E053-731AD00ADF5F","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCB06D-3FC7-7C71-E053-731AD00ADF5F","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-02-02","deletedIndicator":"No"},{"value":"Solid organ tumors unrelated to HPV","valueDescription":null,"ValueMeaning":{"publicId":"12245585","version":"1","preferredName":"Solid Organ Neoplasm HPV Infection Unrelated","longName":"12245585v1.00","preferredDefinition":"An internal organ with firm consistency without a liquid or hollow structural component._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A strain of papillomavirus that can infect the skin and mucous membranes of humans._Not connected or associated e.g. by kinship.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Organ","conceptCode":"C124068","definition":"An internal organ with firm consistency without a liquid or hollow structural component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Human Papillomavirus","conceptCode":"C14226","definition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unrelated","conceptCode":"C25328","definition":"Not connected or associated e.g. by kinship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FCB06D-3FC5-7C71-E053-731AD00ADF5F","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCB06D-3FC8-7C71-E053-731AD00ADF5F","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2022-12-29","deletedIndicator":"No"},{"value":"Kaposi sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3251916","version":"1","preferredName":"Kaposi Sarcoma","longName":"3251916","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A77CE4DC-24A0-EFB7-E040-BB89AD430FFC","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"TSESU","dateModified":"2023-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCB06D-3FC9-7C71-E053-731AD00ADF5F","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2022-12-29","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"3946617","version":"1","preferredName":"Other Diagnosis","longName":"3946617","preferredDefinition":"Different than the one(s) previously specified or mentioned.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA87B0E5-66E5-6876-E040-BB89AD437204","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-06","modifiedBy":"TSESU","dateModified":"2023-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FCB823-9B4D-7DC4-E053-731AD00A06A7","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2022-12-29","deletedIndicator":"No"},{"value":"Hematologic malignancies","valueDescription":null,"ValueMeaning":{"publicId":"4265238","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm","longName":"4265238","preferredDefinition":"A cancer of the blood or bone marrow, such as leukemia or lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic and Lymphoid Cell Neoplasm","conceptCode":"C27134","definition":"A neoplasm that arises from hematopoietic and lymphoid cells. Representative examples include myeloproliferative neoplasms, myelodysplastic syndromes, leukemias, Hodgkin lymphomas, and non-Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-7851-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"TSESU","dateModified":"2023-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FD36F7-B711-1A0C-E053-731AD00AF43C","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2022-12-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3282831","version":"1","preferredName":"Cancer Diagnosis Type","preferredDefinition":"General term for detecting and classifying cancer in patients. (from CSP94):Type; a subdivision of a particular kind of thing.","longName":"C16213:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Diagnosis","conceptCode":"C16213","definition":"General term for detecting and classifying cancer in patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-9F27-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FC825F-373A-745A-E053-731AD00A016E","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CHSRCNTDX","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Initial cancer diagnosis","url":null,"context":"AMC"},{"name":"AMC CRF Text 1","type":"Alternate Question Text","description":"Most recent cancer diagnosis (within 5 years)","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FD66EE-1372-1F2F-E053-731AD00A2101","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"TSESU","dateCreated":"2022-12-29","modifiedBy":"TSESU","dateModified":"2023-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}